FIGURE 2.
MicroRNA biomarkers in personalized medicine. Many infections result in a spectrum of disease severity, including asymptomatic (black), mild (red), and severe (blue) disease. Circulating miRNA signatures may differentiate between these groups and their ultimate disease outcome. This information would allow clinicians to tailor their approach and provide optimal therapeutic interventions.